TrialThe oncologist2020

Bicalutamide plus Aromatase Inhibitor in Patients with Estrogen Receptor-Positive/Androgen Receptor-Positive Advanced Breast Cancer.

Qianyi Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.